NCT01132703View on ClinicalTrials.gov

Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

January 7, 2010

Primary Completion Date

May 7, 2010

Study Completion Date

May 7, 2010

Conditions

Traumatic Brain InjuryStroke

Interventions

DRUG

Glyburide for Injection

Administered as specified in the Treatment Arm.

DRUG

Placebo

Administered as specified in the Treatment Arm.

Trial Locations (1)

49007

Jasper Clinic, Kalamazoo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY